Atlas Trials

Dose Optimized BNCT for Head and Neck Cancer

Clinical trial NCT05883007 · UNKNOWN

Trial details

NCT number
NCT05883007
Sponsor
Southern Tohoku BNCT Research Center
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Head and Neck CancerSquamous Cell Carcinoma
Start date
2020-06-01
Primary completion
2022-05-31
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.